review glp-1 GLP-1-based therapies for diabetes, obesity and beyond GLP-1 receptor agonists effective for

For patients with established atherosclerotic cardiovascular disease, injectable agents with proven outcome data may still be preferred

As in the pathophysiology of DR, RGCs are particularly vulnerable to oxidative stressors in glaucoma

Moreover, liraglutide 3.0 mg (i.e., the dose level approved for weight management for this GLP-1 RA) in combination with lifestyle intervention markedly reduced the presence of visceral fat over a period of 40 weeks (Neeland et al., 2021)

Adv Ther

These treatments are commonly used on the: Face Neck Chest Abdomen Arms For patients with mild to moderate skin laxity, laser treatments may help improve firmness and overall skin appearance with minimal downtime